Max Inhibitors

Common Max Inhibitors include, but are not limited to Selumetinib CAS 606143-52-6, U-0126 CAS 109511-58-2, 10058-F4 CAS 403811-55-2, (+/-)-JQ1 CAS 1268524-69-1 and Rapamycin CAS 53123-88-9.

Max (MYC associated factor X) is a key protein that plays a central role in the regulation of cellular processes, particularly in the modulation of gene expression. Max belongs to the basic helix-loop-helix leucine zipper (bHLHZip) family of transcription factors. This protein can form homodimers or heterodimers with other proteins, most notably with the MYC oncoprotein. While MYC is known to drive cell proliferation and growth, its activity is highly dependent on its dimerization with Max. The MYC-Max complex binds to specific DNA sequences, known as E-boxes, in the promoter regions of target genes, thereby regulating their expression. Conversely, Max can also dimerize with other proteins, forming complexes that repress the transcription of certain genes.

Max inhibitors are molecules designed to disrupt the interaction between Max and its binding partners, especially MYC. Given the significance of the MYC-Max interaction in cellular processes, targeting this protein-protein interaction has become a focal point for researchers. Max inhibitors might function by binding directly to Max, preventing its dimerization with MYC, or by altering its conformation such that it becomes incapable of binding to DNA. These inhibitors can also block the ability of Max to form homodimers or to interact with other transcriptional regulators. By inhibiting Max, these molecules disrupt the cellular activities governed by the MYC-Max complex and other Max-containing complexes. Understanding the molecular basis of Max inhibitors can provide insights into the intricate web of protein interactions and signaling pathways that govern cellular behavior, gene expression patterns, and the broader landscape of cellular regulation.